Diaceutics (LON:DXRX) Stock Price Down 1.6% – What’s Next?

Diaceutics PLC (LON:DXRX) shares traded down 1.6% during mid-day trading on Wednesday . The stock traded as low as GBX 127 ($1.65) and last traded at GBX 127 ($1.65). 5,782 shares changed hands during mid-day trading, a decline of 95% from the average session volume of 111,015 shares. The stock had previously closed at GBX 129 ($1.67).

Analyst Ratings Changes

Separately, Canaccord Genuity Group restated a “buy” rating and issued a GBX 160 ($2.08) price target on shares of Diaceutics in a report on Tuesday, September 17th.

Diaceutics Trading Down 1.6 %

The business’s 50 day simple moving average is GBX 130.60 and its 200 day simple moving average is GBX 123.15. The stock has a market cap of £107.28 million, a price-to-earnings ratio of -4,233.33 and a beta of 0.58. The company has a quick ratio of 9.92, a current ratio of 4.85 and a debt-to-equity ratio of 2.93.

Diaceutics Company Profile

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.